Repurposing the oncolytic virus VSV∆51M as a COVID-19 vaccine by Almohanad A. Alkayyal, Almohanad A. Alkayyal, Manar Darwish, Reham Ajina, Reham Ajina, Saleh Y. Alabbas, Mohammed A. Alotaibi, Abeer Alsofyani, Abeer Alsofyani, Maha Bokhamseen, Maumonah Hakami, Omar A. Albaradie, Omar A. Albaradie, Abdulaziz M. Moglan, Abdulaziz M. Moglan, Sharif Hala, Sharif Hala, Abdullah Faisal Alsahafi, Abdullah Faisal Alsahafi, Samer Zakri, Samer Zakri, Adnan Almuzaini, Khamis Alsharari, Feras Kaboha, Mustafa Y. Taher, Haggag S. Zein, Haggag S. Zein, Fayhan Alroqi, Fayhan Alroqi, Fayhan Alroqi, Ahmad Bakur Mahmoud, Ahmad Bakur Mahmoud, Ahmad Bakur Mahmoud

Get full text